News
With Richard Ayoade with David Letterman, Robert Downey Jr., Kamilah Forbes, Scott Galloway, Tom Hanks, Becky Kennedy, and ...
1h
Barchart on MSNEarnings Preview: What to Expect From Eli Lilly's ReportEli Lilly is expected to release its fiscal second-quarter earnings next month, and analysts project a double-digit profit growth.
Eli Lilly & Co. closed 20.16% below its 52-week high of $972.53, which the company achieved on August 22nd.
A retrospective cohort study found that semaglutide and tirzepatide are linked with significantly lower risks of dementia and ...
22hon MSN
Kiran Musunuru, a University of Pennsylvania cardiologist and leading gene-editing researcher, thinks it’s possible. Musunuru cofounded Verve Therapeutics, a company developing a therapy that uses ...
According to Research by SNS Insider, The U.S. GLP-1 Receptor Agonist Market to Reach USD 113.13 Billion by 2032, Driven by Rising Prevalence of Type 2 Diabetes and Demand for Obesity-Related ...
Explore more
Elecsys pTau181 is the first In Vitro Diagnostic Regulation (IVDR) certified test to rule out Alzheimer’s associated amyloid ...
AstraZeneca plans a $50 billion investment in U.S. facilities by 2030, including a Virginia plant focused on weight loss and ...
23h
Zacks Investment Research on MSNWhy Eli Lilly (LLY) is a Top Growth Stock for the Long-TermTaking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...
AstraZeneca Plc plans to invest US$50bil in the United States before 2030, becoming the latest European pharma company to ...
The money will focus on a manufacturing plant in Virginia that will make the company's weight management and metabolic drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results